EMA: Five-Year Regulatory Network Strategy Still ‘Valid And Relevant’ At Midway Point

A report by the European Medicines Agency outlines the progress that has been made so far in delivering on the key pillars of its five-year network strategy, proposed in 2020, and lists areas where work is ongoing.